Chris Driskill, a Catawba Research Project Manager, joins us to offer some high-level insights on one of our larger trials to date. Chris dives into his notes – and tiny handwriting – to shed light on the rosacea study, which spanned some 33 sites and included 1,116 patients. Hear Chris discuss how the team covered a lot of trial ground to knock out a roughly nine-month turnaround!

Speakers: Zaidoon A. Al-Zubaidy, Chris Driskill and Shannon Weatherly